nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial (Q44558495)
Jump to navigation
Jump to search
scientific article published on 3 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial |
scientific article published on 3 June 2009 |
Statements
1 reference
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial (English)
1 reference
George Dranitsaris
1 reference
Robert Coleman
1 reference
William Gradishar
1 reference
3 June 2009
1 reference
1 reference
119
1 reference
3
1 reference
717-724
1 reference
Identifiers
1 reference
1 reference